Status:
UNKNOWN
DNA Diagnostic System for Statin Safety and Efficacy
Lead Sponsor:
Genomas, Inc
Collaborating Sponsors:
Hartford Hospital
University of California, San Francisco
Conditions:
Hypercholesterolemia
Myopathy
Eligibility:
All Genders
18+ years
Brief Summary
Lipitor®, Zocor®, and Crestor® are statin drugs commonly taken to lower cholesterol and prevent heart disease. Statins lower cholesterol by different amounts in different patients and sometimes statin...
Detailed Description
Statin efficacy in primary and secondary prevention of cardiovascular disease has led to increasingly aggressive usage and dosage of statins. Their main clinically relevant safety risk is statin-induc...
Eligibility Criteria
Inclusion
- receiving, or documented to have received in the past, any of the statins including atorvastatin, simvastatin, rosuvastatin treatment for hypercholesterolemia
- chart-documented clinical record of having had, never having had, or possibly having had, statin-associated myopathy
Exclusion
- never having taken any statin medication
Key Trial Info
Start Date :
January 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT00767130
Start Date
January 1 2007
End Date
December 1 2009
Last Update
October 6 2008
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California-San Francisco
San Francisco, California, United States, 94110
2
Hartford Hospital
Hartford, Connecticut, United States, 06102
3
Rogosin Institute, New York Presbyterian Hospital
New York, New York, United States, 10021